Cargando…
PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses
The peptide vaccine clinical trials encountered limited success because of difficulties associated with stability and delivery, resulting in inefficient antigen presentation and low response rates in patients with cancer. The purpose of this study was to develop a novel delivery approach for tumor a...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356185/ https://www.ncbi.nlm.nih.gov/pubmed/22619507 http://dx.doi.org/10.2147/IJN.S29506 |